A modern strategy for the treatment of diseases associated with Helicobacter pylori is the mandatory inclusion in the scheme of treatment of antibiotics, as well as considering the level of bacterial resistance to the main components of therapy. In Ukraine, Helicobacter pylori infection in some areas can reach about 80%, so the prevalence of peptic ulcer, atrophic gastritis and other diseases of the gastrointestinal tract is extremely high in all sections of the population. Topical for our country is the use of standard triple antyhelicobacter therapy, which includes: proton pump inhibitor in combination with clarithromycin + amoxicillin. Such therapy lasting 10 or 14 days allows to completely free the gastrointestinal tract from Helicobacter pylori, and to prevent the further development of pathological process on the mucous membrane. This tactic can successfully prevent the growth of incidence of gastric lymphoma, cancer of the stomach, as well as reduce the likelihood of complications in peptic ulcers.